Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 44th ...
In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.2% at $449.52. This change lagged the S&P 500's 1.16% loss on the day. Meanwhile, the Dow experienced a drop of 0.47%, and the ...
The Vertex Capital Investment Ltd.-Bond has a maturity date of 7/28/2026 and offers a coupon of 2.8500%. The payment of the coupon will take place 2,0 times per biannual on the 28.01.. The Vertex ...
Months after the CDC eliminated its infection control committee, two epidemiology organizations have created the Healthcare Infection Prevention Advisory Group. The two organizations, the Association ...
The nation’s top brokerage by transaction side count, eXp Realty, first entered the forms business during the summer of 2024, as the real estate industry prepared for the business practice changes ...
Dhruv Bhutani has been writing about consumer technology since 2008, offering deep insights into the Android smartphone landscape through features and opinion pieces. He joined Android Police in 2023, ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in Citi’s 2025 Global Healthcare Conference. Charlie Wagner, Chief Operating and ...
Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback